Login
Register
My Saved
My Account
Cart (
)
Log Out
My Saved
Topics
Assessing CVD Risk
Atherothrombotic Cardiovascular Disease
Cardiovascular Risk Reduction
All of Cardiovascular Risk Reduction
Subtopic 1
Subtopic 2
Subtopic 3
Familial Hypercholesterolemia
Safety and Efficacy of LDL-C Reduction
Faculty Contributors
Educational Tools
Toggle navigation
Assessing CVD Risk
Atherothrombotic Cardiovascular Disease
Cardiovascular Risk Reduction
All of Cardiovascular Risk Reduction
Subtopic 1
Subtopic 2
Subtopic 3
Familial Hypercholesterolemia
Safety and Efficacy of LDL-C Reduction
Faculty Contributors
Educational Tools
Educational Tools
Educational Tools For Your Clinical Practice
For downloadable handouts and online resources, visit below.
Acute Coronary Syndrome
IMPROVE-IT Trial: ACC 2015
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Heart Disease - Patients’ Educational Tool
Diabetes Optimal Care Cardiovascular Risk Reduction (DOC-CARE) EHR “MY CHART”
Guidelines Recommendations on the Use of Platelet Function and Genetic Testing
Atherothrombosis
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Selection of a suitable patient population for new antiplatelet therapy from the large clinical trial database of the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-thrombolysis in myocardial infarction 50 (TRA-2P-TIMI50) trial.
Current APT Recommendations for Longterm Secondary Prevention
DAPT PEGASUS and TRA 2P Trials Primary Efficacy and Safety Outcomes
Cardiac Imaging
Cardiac Stress Testing: Choosing the Right Test and When
Dyslipidemia
2018 Guideline on the Management of Blood Cholesterol - NLA Perspective
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Epidemiology of Dyslipidemia and Economic Burden on the Healthcare System
Prescribing Information for Alirocumab
Prescribing Information for Evolocumab
Diabetic Dyslipidemia: Causes and Consequences
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
ACC Statin Intolerance Tool
2017 NLA Expert Panel on Treatment with PCSK9 Inhibitors
2017 NLA Expert Panel on Treatment with PCSK9 Inhibitors - Infographic
PCSK9 Inhibitor Access Barriers – Issues and Recommendations
Current Indications, Cost, and Clinical Use of Anti-PCSK9 Monoclonal Antibodies
NLA Recommendations for Patient-Centered Management of Dyslipidemia
Patient Information: Reduce Your Risk of Heart Attack and Stroke
High Cholesterol Educational Materials for Patients
Heart Disease: Patient's Educational Tool
Familial Chylomicronemia Syndrome (FCS)
Diagnostic algorithm for FCS
Burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study
Understanding FCS – for Patients
About FCS
Living with FCS – for Patients
2015-2020 Dietary Guidelines
Medications that Increase Triglycerides
FCS References
FCS Clinical Studies
Familial Hypercholesterolemia
Learning About Familial Hypercholesterolemia
Heart Failure
Frequently Asked Questions About Heart Failure – for Patients
PARADIGM-HF Trial of Sacubitril/Valsartan
Hypertension
2017 Guideline for High Blood Pressure in Adults
High Blood Pressure Information for Patients
Treatment of resistant hypertension
CDC High Blood Pressure Fact Sheet
Million Hearts® Hypertension Control: Action Steps for Clinicians
Systolic Blood Pressure Intervention Trial (SPRINT)
Hypertriglyceridemia
REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial. AHA 2018.
A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids
Hypertriglyceridemia and atherosclerosis
Hypertriglyceridemia and omega-3 fatty acids: Their often-overlooked role in cardiovascular disease prevention
Fish and Omega-3 Fatty Acids
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease
Is triglyceride therapy worth the effort?
AHA Recommendations for Omega‐3 Fatty Acids Intake
Venous Thromboembolism
What is Venous Thromboembolism?
Antithrombotic Therapy for VTE Disease
Wells’ Criteria for Pulmonary Embolism
×
Close
Notice